Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America

SUGAR LAND--January 20, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As the first quarter of 2015 gathers steam, the Pharmaceutical-Biotech Industry is projected to launch $3.9 billion worth of North American projects through the end of March. A healthy cash injection of that magnitude is cause for jubilation, or at the least, cautious optimism.

Within this article: Details on the industry's North American kickoffs in first-quarter 2015, including major projects from AstraZeneca (NYSE:AZN), Gilead Sciences (NASDAQ:GILD) and the U.S. Army Public Health Command.